1. Assessment of antibody responses against SARS-CoV-2 in unvaccinated individuals and vaccinees from Omicron-BA.2 infection in Zhaoqing, Guangdong Province, China
- Author
-
Huan Zhang, Yushan Jiang, Hanqing Tan, Lirong Zou, Zhonghua Zheng, Yushi Huang, Shujian Lin, Lebin Su, Jianxiang Yu, Xiaoling Deng, Jianfeng He, Chang Liu, Chenguang Shen, and Baisheng Li
- Subjects
Omicron-BA.2 ,Breakthrough infection ,Antibody responses ,IgM ,Neutralization antibody ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Currently, the majority of the global population has been vaccinated with the COVID-19 vaccine, and characterization studies of antibodies in vivo from Omicron breakthrough infection and naive infection populations are urgently needed to provide pivotal clues about accurate diagnosis, treatment, and next-generation vaccine design against SARS-CoV-2 infection. We showed that after infection with Omicron-BA.2, the antibody levels of specific IgM against the Wuhan strain and specific IgG against Omicron were not significantly elevated within 27 days of onset. Interestingly, in this study, the levels of humoral immunity against Omicron-specific IgM were significantly increased after breakthrough infection, suggesting that the detection of Omicron-specific IgM antibodies can be used as a test criterion of Omicron breakthrough infection. In addition, we observed that serums from unvaccinated individuals and the majority of vaccinated infections possessed only low or no neutralizing activity against Omicron at the onset of Omicron breakthrough infections, and at the later stage of Omicron-BA.2 breakthrough infection, levels of neutralization antibody against the Wuhan and Omicron strains were elevated in infected individuals. The findings of this study provide important clues for the diagnosis of Omicron breakthrough infections, antibody characterization studies and vaccine design against COVID-19.
- Published
- 2022
- Full Text
- View/download PDF